Search |

Add/Edit My Facility

Sylvester Cancer Modeling Shared Resource

University of Miami

Contact Info:

Daniel Bilbao

1580 NW 10th Ave

Miami, FL 33136

https://www.sylvester.org/CMSR

Grants and Identifiers:

RRID: RRID:SCR_022891

Other Citation Identifiers

P30-CA240139

Instrumentation:

Bruker 9.4T Biospec Biospec Magnetic Resonance Imaging

The BioSpec® series is an MRI system that performs preclinical and molecular MR imaging. MRI CryoProbe™ technology combined with ultra high field USR magnets deliver high spatial resolution in-vivo, thus enabling customers to come closer to the molecular and cellular level research they desire. Thanks to its innovative modular concept, virtually any small animal MR imaging application in life science, biomedical and preclinical research can be conducted. [Product Link]

RRID:SCR_018054

cite this instrument

Leica CM1950 Cryostat

The Leica CM1950 is a highly adaptable cryostat platform that can be tailor-made for each laboratory. By starting with the standard instrument and choosing from a range of options, every laboratory can have a clinical cryostat for their individual needs. Innovation and human-oriented features provide a cryostat with a new level of performance. The CM1950 is a high-performance cryostat with an encapsulated microtome and separate specimen cooling. It features a UV disinfection system, an (optional) integrated extraction system for section waste and an (optional) motor for motorized sectioning. The cryostat is designed to produce frozen sections for biological, medical and industrial applications. The CM1950 is suitable for in-vitro diagnostic (IVD) applications. [Product Link]

RRID:SCR_018061

cite this instrument

Miltenyi gentleMACS Dissociator Tissue Dissociator

Benchtop instrument for semi automated dissociation of tissues into single cell suspensions or thorough homogenates. Single sample or two samples in parallel can be processed. [Product Link]

RRID:SCR_020267

cite this instrument

Perkin Elmer IVIS Spectrum In-Vivo Imaging System

In vivo imaging system that combines two dimensional and three dimensional optical tomography. It can be used for non invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals. [Product Link]

RRID:SCR_018621

cite this instrument

FUJIFILM VisualSonics Vevo 3100

Ultrasound imaging

Heska DRI-CHEM 7000

veterinary chemistry analyzer

Leica BOND-RXm

automated IHC

Leica Histocore Arcadia H/C

paraffin embedding station

Leica Histocore autocut

microtome

Leica ST5020

slide stainer with automatic coverslipper

MILabs VECTor

PET/SPECT/CT imager

Olympus VS200

whole slide scanner

Xstrahl RS225

irradiator

XStrahl SARRP 200

image-guided X-ray irradiator

Services Provided:

Animal Husbandry

Chemistry Analyzer

Clinical Imaging - Small Animal (luminescence/fluorescence)

Clinical Imaging - Small Animal (X-ray, Ultrasound, microCAT, MRI)

Colony Management

Cryostat Histology

H&E Staining

Histology

In-vivo Imaging

Irradiation

MicroCT

Pharmacokinetics

Positron Emission Tomography (PET)

Processing & Embedding- Histology

Veterinary Pathology

Whole Slide Imaging

Xenograft / Xenotransplantation

Relevant Publications:

1.) Galoian K, Bilbao D, Denny C, Campos Gallego N, Roberts E, Martinez D, Temple HT (2024 Dec 19). Targeting cancer stem cells by TPA leads to inhibition of refractory sarcoma and extended overall survival. Molecular therapy. Oncology, 32(4), 200905. . PMID: 39640862.


2.) Elledge C, Zhang Y, Shin SU, Cho HM, Ramakrishnan S, Sankar A, Chapman JR, Bilbao D, Das R, Gil-Henn H, Lossos IS, Rosenblatt JD (2024 Nov 6). Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma-Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein. Cells, 13(22), . . PMID: 39594584.


3.) Yenisehirli G, Borges S, Braun SS, Zuniga AN, Quintana GI, Kutsnetsoff JN, Rodriguez S, Adis EV, Lopez S, Dollar JJ, Stathias V, Volmar CH, Karaca E, Brothers S, Bilbao D, Harbour JW, Correa ZM, Kurtenbach S (2024 Oct 11). Identification of targetable epigenetic vulnerabilities in uveal melanoma. bioRxiv : the preprint server for biology, (), . . PMID: 39416076.


4.) Manara P, Newsam AD, Saralamma VV, Russo MV, Martinez AB, Fattakhov N, Cunningham TA, Alaoui AY, Chahar D, Carbone AM, Lightfuss OB, Barroso AM, Hoffman KS, Maura F, Bilbao D, Schatz JH (2024 Sep 13). NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy. bioRxiv : the preprint server for biology, (), . . PMID: 39314323.


5.) Chaudhry S, Beckedorff F, Jasdanwala SS, Totiger TM, Affer M, Lawal AE, Montoya S, Tamiro F, Tonini O, Chirino A, Adams A, Sondhi AK, Noudali S, Cornista AM, Nicholls M, Afaghani J, Robayo P, Bilbao D, Nimer SD, Rodríguez JA, Bhatt S, Wang E, Taylor J (2024 Sep). Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition. Leukemia, 38(9), 1894-1905. . PMID: 38997434.


6.) Kurtenbach S, Sanchez MI, Kuznetsoff J, Rodriguez DA, Weich N, Dollar JJ, Cruz A, Kurtenbach S, Field MG, Durante MA, Decatur C, Sorouri M, Lai F, Yenisehirli G, Fang B, Shiekhattar R, Pelaez D, Correa ZM, Verdun RE, Harbour JW (2024 Feb). PRAME induces genomic instability in uveal melanoma. Oncogene, 43(8), 555-565. . PMID: 38030788.


7.) Hersh J, Yang YP, Roberts E, Bilbao D, Tao W, Pollack A, Daunert S, Deo SK (2023 Jul 19). Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody-Gaussia Luciferase Fusion Protein. Pharmaceutics, 15(7), . . PMID: 37514162.


8.) Gonzalez GC, Li CM, Pasolini I, Pete SI, Verheyen C, Vignolo SM, De Toni T, Stock AA, Tomei AA (2025 Jan-Dec). High-Yield Generation of Glucose-Responsive Pseudoislets From Murine Insulinoma Cells for In Vitro Studies and Longitudinal Monitoring of Graft Survival In Vivo. Cell transplantation, 34(), 9636897251315123. . PMID: 39881520.


Description:

The Sylvester Cancer Modeling Shared Resource (CMSR) provides state-of-the-art preclinical cancer modeling services to foster cancer research and to accelerate the discovery of tailored anti-tumor therapies, including preclinical data for drug development, proof of principle for novel therapies, preclinical imaging, and disease biomarker studies. The CMSR’s integrated services include facilitating the in vivo modeling of human disease using murine models; supporting preclinical in vivo efficacy and toxicity studies; devising treatment protocols; using noninvasive imaging for diagnosis and evaluation of responses to treatment; and performing histopathological analysis of targeted cancer therapies. Specific services include (1) support for the development of experimental murine models of cancer, including with cell line and patient-derived xenografts (PDXs), genetically engineered models, and humanized models; (2) support for devising and implementing treatment protocols in a pre-clinical setting using murine models of human disease (e.g., drug toxicology and efficacy studies, drug formulation and delivery, and related assessments, like cell blood count, clinical chemistry, and flow cytometry analysis); and (3) diagnosis and evaluation of responses to treatment, using noninvasive small animal imaging for diagnosis and evaluation of responses to treatment, including in vivo bioluminescence and fluorescence optical imaging, high-frequency ultrasound imaging, structural and functional nuclear imaging, and magnetic resonance imaging (MRI); and (b) research histopathological analysis of targeted cancer therapies, including H&E and immunohistochemistry (IHC) sectioning, staining, scanning and analysis, and data storage of digital slide images. The CMSR also offers consultation, training, educational workshops and seminars. CMSR radiotherapy services support both small animal total body and image-guided radiation treatment delivery with sub-millimetric accuracy for development of radiation therapy regimens in a preclinical setting.